CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net loss	$ (68,147)	$ (12,114)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	17,094	9,626
Unrealized loss (gain) on foreign currency	2,811	(254)
Stock based compensation	15,224	347
Change in fair value of warrants	(3,359)
Change in fair value of derivative liability	(3,225)
Amortization of debt discount and deferred issuance costs	2,527
Deferred income tax	2,088	(4,299)
Provision for doubtful accounts	554	(613)
Unrealized gain on investment	(1,260)
Non-cash lease expense	9,727
Changes in operating assets and liabilities:
Accounts receivable	51,831	33,793
Prepaid expenses and other current assets and prepaid expenses and other assets	(3,216)	(7,778)
Accounts payable	(1,167)	588
Deferred rent		(1,147)
Accrued compensation	(7,242)	351
Accrued expenses, other current liabilities and other liabilities	(7,733)	(2,997)
Lease liabilities	(11,592)
Deferred revenue	1,284	(248)
Cash (used in) provided by operating activities	(3,801)	15,255
Investing activities:
Capital expenditures	(2,828)	(970)
Capitalization of internal-use software	(6,646)	(4,286)
Cash from acquired business, net		5,200
Cash (used in) provided by investing activities	(9,474)	(56)
Financing activities:
Proceeds from issuance of common stock		35,000
Proceeds from exercise of stock options	360	287
Payment for shares withheld for employee taxes	(1,635)
Borrowings (payments) on revolving credit facilities	5,000	(1,304)
Deferred reverse recapitalization costs	(585)
Cash provided by (used in) financing activities	3,140	33,983
Effect of currency translation on cash and cash equivalents	(1,409)	(499)
Net (decrease) increase in cash, cash equivalents and restricted cash	(11,544)	48,683
Cash and cash equivalents and restricted cash at beginning of period	79,733	106,126
Cash and cash equivalents and restricted cash at end of period	$ 68,189	$ 154,809